BioAge Labs (BIOA) Non Operating Income (2023 - 2026)
BioAge Labs (BIOA) posted Non Operating Income of $3.1 million for Q1 2026, up 25.89% sequentially from $2.5 million in Q4 2025, and down 11.26% YoY from $3.5 million in Q1 2025.
BioAge Labs (BIOA) Non Operating Income (2023 - 2026) Analysis & Trends
BioAge Labs has reported Non Operating Income for 4 years, with the latest figure at $3.1 million in Q1 2026.
- Quarterly Non Operating Income fell 11.26% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.8 million (up 9.25% YoY) and the FY2025 annual result came in at $12.2 million, up 71.84% from the prior year.
- Non Operating Income grew to $3.1 million in Q1 2026 per BIOA's latest filing, from $2.5 million in the prior quarter.
- Over five years, Non Operating Income peaked at $4.2 million in Q4 2024 and troughed at -$7.4 million in Q4 2023.
- A 4-year average of $934727.3 and a median of $2.5 million in 2025 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 2065.36% in 2025, down 41.41% in 2025.
- Over 4 years, Non Operating Income stood at -$7.4 million in 2023, then soared by 157.5% to $4.2 million in 2024, then plunged by 41.41% to $2.5 million in 2025, then grew by 25.89% to $3.1 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $3.1 million, $2.5 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | BioAge Labs | 439.65 Mn | 439.65 Mn | -14.23 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.24 Mn |
| Mar 31, 2026 | 3.12 Mn |
| Dec 31, 2025 | 2.48 Mn |
| Sep 30, 2025 | 2.97 Mn |
| Jun 30, 2025 | 3.21 Mn |
| Mar 31, 2025 | 3.52 Mn |
| Dec 31, 2024 | 4.23 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.69 Mn |
| Mar 31, 2024 | -179,000.00 |
| Dec 31, 2023 | -7.36 Mn |
| Sep 30, 2023 | -4.74 Mn |